Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid.
Pilatrino C, Cilloni D, Messa E, Morotti A, Giugliano E, Pautasso M, Familiari U, Cappia S, Pelicci PG, Lo Coco F, Saglio G, Guerrasio A. Pilatrino C, et al. Among authors: messa e. Cancer. 2005 Jul 1;104(1):101-9. doi: 10.1002/cncr.21132. Cancer. 2005. PMID: 15895376 Free article. Clinical Trial.
A young man with persistent eosinophilia.
Messa E, Cilloni D, Saglio G. Messa E, et al. Intern Emerg Med. 2007 Jun;2(2):107-12. doi: 10.1007/s11739-007-0030-1. Intern Emerg Med. 2007. PMID: 17622494 No abstract available.
Myelodysplastic syndromes.
Cilloni D, Messa F, Carturan S, Arruga F, Defilippi I, Messa E, Gottardi E, Saglio G. Cilloni D, et al. Among authors: messa e, messa f. Ann N Y Acad Sci. 2004 Dec;1028:400-8. doi: 10.1196/annals.1322.048. Ann N Y Acad Sci. 2004. PMID: 15650265 Review.
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy.
Cilloni D, Messa F, Arruga F, Defilippi I, Gottardi E, Fava M, Carturan S, Catalano R, Bracco E, Messa E, Nicoli P, Diverio D, Sanz MA, Martinelli G, Lo-Coco F, Saglio G. Cilloni D, et al. Among authors: messa e, messa f. Haematologica. 2008 Jun;93(6):921-4. doi: 10.3324/haematol.12165. Epub 2008 Apr 28. Haematologica. 2008. PMID: 18443273 Free article.
Emerging drugs for chronic myeloid leukemia.
Cilloni D, Messa E, Rotolo A, Saglio G. Cilloni D, et al. Among authors: messa e. Expert Opin Emerg Drugs. 2010 Jun;15(2):175-84. doi: 10.1517/14728211003621220. Expert Opin Emerg Drugs. 2010. PMID: 20201747 Review.
Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging.
Messa E, Carturan S, Maffè C, Pautasso M, Bracco E, Roetto A, Messa F, Arruga F, Defilippi I, Rosso V, Zanone C, Rotolo A, Greco E, Pellegrino RM, Alberti D, Saglio G, Cilloni D. Messa E, et al. Haematologica. 2010 Aug;95(8):1308-16. doi: 10.3324/haematol.2009.016824. Epub 2010 Jun 9. Haematologica. 2010. PMID: 20534700 Free PMC article.
Iron chelation therapy in myelodysplastic syndromes.
Messa E, Cilloni D, Saglio G. Messa E, et al. Adv Hematol. 2010;2010:756289. doi: 10.1155/2010/756289. Epub 2010 Jun 20. Adv Hematol. 2010. PMID: 20672005 Free PMC article.
30 results